Vylor Reaffirms 2026 Guidance, EBITDA Loss Narrows to $269M

Vylor, Inc. (NYSE: VYLR) reported a third-quarter GAAP pro forma net loss from continuing operations of $480 million, or $0.72 per share, on pro forma net sales of $938 million, the seed and genetics company said on November 11, 2026. Adjusted Pro Forma Operating EBITDA was a loss of $269 million, 33% wider than a year earlier, while pro forma organic sales fell 3%. For the nine months to September 30, GAAP pro forma income from continuing operations reached $1.01 billion, or $1.50 per share, on $8.53 billion of pro forma net sales.

Context — why Vylor's guidance matters now

The results land weeks after Vylor completed a separation transaction and hosted its first Investor Day on September 15, 2026. The company said the separation "marked an important milestone," positioning it to move faster and sharpen focus. That framing matters because the quarter is the first clean read on Vylor as a standalone seed and genetics business, and it sets the base from which the company's 2029 Financial Framework is measured.

The framework targets net sales of roughly $11.2 billion to $11.9 billion by 2029, representing 3% to 4% annual growth over the planning period, operating EBITDA of about $3.3 billion to $3.7 billion, and roughly 30% operating EBITDA margins. Vylor also flagged a $19 billion technology pipeline anchored by twelve platform launches across corn, soybean and wheat over the next decade.

Management tied the quarter to that longer arc. Chief Executive Officer Chuck Magro said the company delivered "meaningful EBITDA growth and margin expansion," driven by demand for its technologies, productivity improvements and commercial execution. He added the company remains on track to meet its 2026 commitments.

On the demand side, the company described a constructive agricultural backdrop: strong grain and oilseed demand, improved crop prices and growing renewable-fuel consumption. It also flagged weather, including El Nino effects, and trade dynamics as sources of uncertainty and commodity-price volatility.

The catalyst chain runs from the separation to the Investor Day to the reaffirmed outlook. Each step narrowed what investors must price: standalone cost structure, licensing income ramp, and the dividend and buyback that now anchor capital returns.

Data — what the numbers show

The third quarter was weaker than the nine-month trend on almost every line. Pro forma net sales slipped 1% year over year to $938 million, and organic sales dropped 3%. Volume fell 9% overall, with Americas volume down 6% and Rest of World volume down 16%. Price/mix rose 6%, cushioned by licensing income.

Segment detail shows where the pressure sat. Americas pro forma net sales rose 3% to $613 million, with corn up 13% to $432 million and soybeans down 26% to $128 million. The Americas segment posted an adjusted operating EBITDA loss of $84 million, an improvement of 19% from a year earlier, with margin up roughly 380 basis points.

Rest of World pro forma net sales fell 7% to $325 million. Corn there dropped 14% to $175 million, while other oilseeds rose 14% to $136 million. Rest of World adjusted operating EBITDA was $92 million, down 31%, with margin off about 1,000 basis points.

Metric	3Q 2026	3Q 2025	Change
Pro forma net sales	$938M	$944M	(1)%
Adj. pro forma op. EBITDA	($269M)	—	(33)%
Americas segment EBITDA	($84M)	($104M)	+19%
Rest of World segment EBITDA	$92M	$134M	(31)%

For the nine months, pro forma net sales rose 4% to $8.53 billion, with organic sales up 2%. Adjusted Pro Forma Operating EBITDA reached $2.66 billion, up 8%, and adjusted pro forma operating EPS was $2.37, up 6%. Americas nine-month EBITDA rose 11% to $2.88 billion; Rest of World fell 2% to $555 million.

Analysis — what it means for markets and sectors

The split between nine-month strength and third-quarter softness is the central tension. Year-to-date EBITDA growth of 8% sits against a quarterly EBITDA loss that widened 33%, which means the reaffirmed full-year target depends on fourth-quarter delivery. Vylor guides to roughly $2.8 billion of adjusted pro forma operating EBITDA for 2026, growth of 10% at the midpoint, and adjusted pro forma operating EPS of $2.25 to $2.35, growth of 5% at the midpoint.

Second-order effects run through the agricultural input chain. Vylor's licensing push, including the Vylor One business targeting about $500 million in gross licensing income in 2027, shifts revenue away from pure seed volume toward royalty streams. That model lowers capital intensity but ties results to partner acreage decisions, which the Brazil soybean shift already demonstrated by cutting quarterly soybean sales 26%.

Sector exposure is concentrated in seed, crop-chemical and farm-machinery names that trade on planted-acre expectations, plus biofuel-linked demand for corn and soy. Weather-driven corn acreage losses in Europe and India, and delayed monsoons, are the kind of volume shocks that ripple into fertilizer and equipment order books.

The counter-argument is that the quarterly miss is timing, not deterioration. Earlier North American soybean planting and the deliberate Brazil licensing switch pulled volume out of the quarter, while price/mix of 6% shows pricing power intact. If that read is right, the nine-month trend is the better signal.

Positioning reflects that debate. Investors leaning on the 2029 framework and the new capital-return program have reason to hold; those focused on the quarterly EBITDA loss may trim. The company did not disclose how the buyback will be funded or paced.

Outlook — what to watch next

The near-term catalyst is the third-quarter earnings call on November 12, 2026, at 9:00 a.m. ET, where management will discuss results and the outlook. The accompanying slide presentation is posted on the company's Investor Events and Presentations page, and a replay will follow.

The dividend of $0.13 per share is payable December 7, 2026, to shareholders of record as of November 30, 2026. The $3 billion multi-year share repurchase program is effective immediately with no expiration date, and the company said it balances research and development spending with dividends, buybacks and strategic M&A.

Operationally, watch fourth-quarter execution against the roughly $2.8 billion EBITDA target and the $2.25 to $2.35 EPS range. The company does not provide a comparable GAAP measure on a forward-looking basis, citing items outside its control.

Frequently Asked Questions

What does Vylor's third-quarter loss mean for retail investors?

The loss is a GAAP pro forma figure of $480 million, or $0.72 per share, reflecting separation-related and non-recurring items, while the non-GAAP adjusted operating EBITDA loss was $269 million. The nine-month picture is profitable: $1.01 billion of GAAP pro forma income and $2.37 of adjusted operating EPS. Retail investors should weigh the quarterly loss against the reaffirmed full-year guidance and the newly authorized dividend and buyback.

What happens next for Vylor stock after the guidance reaffirmation?

The company hosts its earnings call on November 12, 2026, at 9:00 a.m. ET. The dividend pays December 7, 2026, and the $3 billion repurchase program is active with no expiration date. The key test is whether fourth-quarter results support roughly $2.8 billion of adjusted operating EBITDA and $2.25 to $2.35 of adjusted operating EPS.

Why did Vylor's soybean sales fall 26% in the third quarter?

Americas soybean sales dropped 26% to $128 million, which the company attributed to a shift to a licensing model in Brazil and an earlier planting season in North America. The licensing model converts seed sales into royalty income, so reported volume falls even when underlying technology adoption holds. Total company volume fell 9%, with price/mix up 6% partly on higher licensing income.

Bottom Line

Vylor reaffirmed 2026 guidance on 8% year-to-date EBITDA growth, but the widening third-quarter loss leaves fourth-quarter execution as the swing factor.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.